Navigation Links
Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies
Date:10/6/2010

NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 6 /PRNewswire/ -- HealthLeaders-InterStudy and Fingertip Formulary find that due to the rising costs of asthma and chronic obstructive pulmonary disease (COPD) drugs, managed care organization pharmacy directors will tighten their formularies. According to the report entitled Formulary Advantages in Asthma and COPD, the majority of surveyed pharmacy directors expect asthma and COPD drug prices to increase over the next five years by an average of three percent annually and believe they can implement tightened formulary strategies to slow down this trend.

The arrival of generics and branded generics may lead managed care organizations to include only the highest-rebating therapy on Tier 2 and shift other medications within a drug class to Tier 3 or exclude them from their formulary altogether. Novel branded long-acting beta-2 agonists and inhaled corticosteroid (LABA/ICS) combination therapies are expected to launch in 2013-2014 and will generate enough competition to spur the use of higher rebates for tier placement.

"As the price for asthma and COPD drugs increases and competition among therapies grows, more plans will consider tightened formularies and formulary exclusion," said HealthLeaders-InterStudy Analyst Roy Moore, author of the report. "Medicare plans are taking the lead with tighter formularies. Pharmaceutical companies will have to consider using rebates to ensure preferred formulary status for asthma and COPD drugs on most health plans."

The new Formulary Forum report is based on a survey of 47 U.S. pharmacy directors who control formularies at national, regional and state-level managed care organizations, as well as historical formulary data from Fingertip Formulary.

About Fingertip FormularyFingertip Formulary (www.FingertipFormulary.com), the leading provider of access to and insight into formulary data in the United States, offers comprehensive formulary data covering commercial, Medicaid, Medicare and PBM plans, among others. Fingertip Formulary is a Decision Resources, Inc. company.

About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Both HealthLeaders-InterStudy and Fingertip Formulary are Decision Resources, Inc. companies. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Erin O'Leary

Elizabeth MarshallHealthLeaders-InterStudy

Decision Resources, Inc. 781-993-2641

781-993-2563eoleary@dresources.com

emarshall@dresources.com
'/>"/>

SOURCE HealthLeaders-InterStudy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
2. Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers
3. Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly
4. Roches Quinn Honored as 2010 HBA Rising Star
5. Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa, Says Frost & Sullivan
6. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
7. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
8. Study Says Allergy Shots Help Children, Reduce Health Care Costs
9. Drug Combo Could Lower Diabetes Complications and Costs
10. DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
11. Complications and Costs for Obesity Surgery Declining
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)...  This report by Persistence Market Research examines ... the period 2016–2024. The primary objective of the ... to market opportunities in the global peripherally inserted ... the various dynamics that are expected to influence ... global peripherally inserted central catheters market over the ...
(Date:1/16/2017)... 2017   The Harrington Discovery Institute ... , has announced the 2017 recipients of ... of physician-scientists whose research shows promise to advance ... Discovery Institute – part of The Harrington Project ... in academic medicine: to advance early breakthroughs into ...
(Date:1/16/2017)... PORTLAND, Oregon and PUNE, India ... report published by Allied Market Research, titled, "Vital Signs Monitoring ... and Industry Forecast, 2014-2022", projects that the global vital signs ... and is expected to reach $5,491 million by 2022, growing ... North America was the leading regional market ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... 16, 2017 , ... With the Grand Opening Event planned for February 3, ... sports teams and the general public. Built in five months by Centerpoint, the 60,000 ... into basketball or pickleball courts. The space is also suitable for indoor soccer and ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... their recent partnership with an innovator in the wheelchair accessibility industry, BraunAbility ... their dealer salespeople to sell wheelchair accessible vehicles. With this new incentive plan, ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Aesthetic Surgery Journal , the official journal of The American Society for Aesthetic ... retraction surgery. The procedure is designed to correct drooping, retracted lower eyelids, which ...
Breaking Medicine News(10 mins):